Cargando…

Genetic Analysis of the Early Natural History of Epithelial Ovarian Carcinoma

BACKGROUND: The high mortality rate associated with epithelial ovarian carcinoma (EOC) reflects diagnosis commonly at an advanced stage, but improved early detection is hindered by uncertainty as to the histologic origin and early natural history of this malignancy. METHODOLOGY/PRINCIPAL FINDINGS: H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pothuri, Bhavana, Leitao, Mario M., Levine, Douglas A., Viale, Agnès, Olshen, Adam B., Arroyo, Crispinita, Bogomolniy, Faina, Olvera, Narciso, Lin, Oscar, Soslow, Robert A., Robson, Mark E., Offit, Kenneth, Barakat, Richard R., Boyd, Jeff
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2859950/ https://www.ncbi.nlm.nih.gov/pubmed/20436685 http://dx.doi.org/10.1371/journal.pone.0010358

Ejemplares similares

Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma
por: Ducie, Jennifer, et al.
Publicado: (2017)

Homologous recombination deficiency (HRD) testing in ovarian cancer clinical practice: a review of the literature
por: Frey, Melissa K., et al.
Publicado: (2017)

Transient rise in CA 125 in a woman with ovarian carcinoma and COVID-19 infection
por: Smith, Maria, et al.
Publicado: (2020)

Successful treatment of platinum refractory ovarian clear cell carcinoma with secondary cytoreductive surgery and implantable transponder placement to facilitate targeted volumetric arc radiation therapy
por: Fehniger, Julia, et al.
Publicado: (2018)

Concomitant loss of SMARCA2 and SMARCA4 expression in small cell carcinoma of the ovary, hypercalcemic type
por: Jelinic, Petar, et al.
Publicado: (2016)

Treating through the surge: institutional experience of definitive management of cervical cancer patients at an urban institution during the COVID-19 pandemic
por: Lee, Sarah, et al.
Publicado: (2021)

Analysis of genetic variation in Ashkenazi Jews by high density SNP genotyping
por: Olshen, Adam B, et al.
Publicado: (2008)

Medical marijuana utilization in gynecologic cancer patients
por: Fehniger, Julia, et al.
Publicado: (2021)

PO40 Presentation Time: 4:45 PM: Definitive Management of Cervical Cancer Patients at an Urban Institution During the COVID-19 Pandemic - Brachytherapy Treatment During the Surge
por: Lymberis, Stella C., et al.
Publicado: (2022)

Molecular Subtypes of Uterine Leiomyosarcoma and Correlation with Clinical Outcome()()
por: Barlin, Joyce N., et al.
Publicado: (2015)

Noninvasive ovarian cancer biomarker detection via an optical nanosensor implant
por: Williams, Ryan M., et al.
Publicado: (2018)

Utility of endometrial sampling prior to risk-reducing hysterectomy in a patient with Lynch syndrome
por: Frey, Melissa K, et al.
Publicado: (2016)

A pair of datasets for microRNA expression profiling to examine the use of careful study design for assigning arrays to samples
por: Qin, Li-Xuan, et al.
Publicado: (2018)

CCNE1 amplification among metastatic sites in patients with gynecologic high-grade serous carcinoma
por: Margolis, Benjamin, et al.
Publicado: (2021)

Immune-Active Microenvironment in Small Cell Carcinoma of the Ovary, Hypercalcemic Type: Rationale for Immune Checkpoint Blockade
por: Jelinic, Petar, et al.
Publicado: (2018)

Genome-wide analysis of the role of copy-number variation in pancreatic cancer risk
por: Willis, Jason A., et al.
Publicado: (2014)

miR-200c-driven Mesenchymal-To-Epithelial Transition is a Therapeutic Target in Uterine Carcinosarcomas
por: Tseng, Jill H., et al.
Publicado: (2017)

Natural history of ovarian cancer
por: Vargas, Arturo Novoa
Publicado: (2014)

Parafunciones en escolares de 12 a 15 años de la Escuela Secundaria Técnica Industrial No. 99 de Boca del Río, Veracruz.
por: Arroyo Olvera, Alberto
Publicado: (2008)

Natural history of ovarian endometrioma in pregnancy
por: Pateman, Katie, et al.
Publicado: (2014)

Gene Expression Differences between Enriched Normal and Chronic Myelogenous Leukemia Quiescent Stem/Progenitor Cells and Correlations with Biological Abnormalities
por: Affer, M., et al.
Publicado: (2011)

Promoter hypermethylation-mediated inactivation of multiple Slit-Robo pathway genes in cervical cancer progression
por: Narayan, Gopeshwar, et al.
Publicado: (2006)

Ovarian surface epithelium: family history and early events in ovarian cancer
por: Wong, Alice ST, et al.
Publicado: (2003)

Heterotypic CAF-tumor spheroids promote early peritoneal metastatis of ovarian cancer
por: Gao, Qinglei, et al.
Publicado: (2019)

A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment
por: Robson, Mark E, et al.
Publicado: (2004)

Correction: Heterotypic CAF-tumor spheroids promote early peritoneal metastatis of ovarian cancer
por: Gao, Qinglei, et al.
Publicado: (2019)

Clinical trials, adaptability and the COVID-19 pandemic
por: Eskander, Ramez N., et al.
Publicado: (2020)

Immunohistochemical Characterization of Normal Ovary and Common Epithelial Ovarian Neoplasm with a Monoclonal Antibody to Cytokeratin and Vimentin
por: Goel, Ankita, et al.
Publicado: (2018)

Fault-Tolerant indoor localization based on speed conscious recurrent neural network using Kullback–Leibler divergence
por: Varma, Pothuri Surendra, et al.
Publicado: (2022)

Natural History of Cardiomyopathy in Adult Dogs With Golden Retriever Muscular Dystrophy
por: Guo, Lee‐Jae, et al.
Publicado: (2019)

Ovarian cancer screening in menopausal females with a family history of breast or ovarian cancer
por: Lai, Tiffany, et al.
Publicado: (2016)

Graphic Scientific History: As Illustrated by the History of Physiology
por: Richards, Oscar W.
Publicado: (1927)

Epithelial ovarian cancer relapsing as isolated lymph node disease: natural history and clinical outcome
por: Legge, Francesco, et al.
Publicado: (2008)

Quality-adjusted time without symptoms of disease or toxicity and quality-adjusted progression-free survival with niraparib maintenance in first-line ovarian cancer in the PRIMA trial
por: Barretina-Ginesta, Maria-Pilar, et al.
Publicado: (2022)

Letter to the Editor regarding the manuscript entitled: “Prevalence of occult gynecologic malignancy at the time of risk reducing and nonprophylactic surgery in patients with Lynch syndrome” by Lachiewicz et al. (Gynecol Oncol. 2014; 132: 434–437)
por: Soslow, Robert A.
Publicado: (2014)

Ovarian Actinomycosis: Presenting as Ovarian Mass Without Any History of Intra-Uterine Copper Device
por: Singh, Sunita, et al.
Publicado: (2012)

Survival and recurrence after intraperitoneal chemotherapy use: Retrospective review of ovarian cancer hospital registry data
por: Adambekov, Shalkar, et al.
Publicado: (2020)

Completeness of pedigree and family cancer history for ovarian cancer patients
por: Son, Yedong, et al.
Publicado: (2014)

History of Endometriosis Is Independently Associated with an Increased Risk of Ovarian Cancer
por: Sarría-Santamera, Antonio, et al.
Publicado: (2022)

History of an artist
por: Peterson, Oscar, 1925-
Publicado: (1993)

Cannot write session to /tmp/vufind_sessions/sess_sslee21tq5h1cj0plm33h7huon